Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Mometasone furoate
Drug ID BADD_D01491
Description Mometasone furoate is a corticosteroid drug that can be used for the treatment of asthma, rhinitis, and certain skin conditions[FDA Label][F4292,F4295]. It has a glucocorticoid receptor binding affinity 22 times stronger than [dexamethasone] and higher than many other corticosteroids as well[A176906]. Mometasone furoate is formulated as a dry powder inhaler, nasal spray, and ointment for its different indications[FDA Label][F4292,F4295].
Indications and Usage The inhaler is indicated for the maintenance treatment of asthma as prophylactic therapy. The nasal spray is indicated for the treatment of the nasal symptoms of seasonal allergic and perennial allergic rhinitis.
Marketing Status Prescription; Discontinued
ATC Code D07AC13; D07XC03; R01AD09; R03BA07
DrugBank ID DB14512
KEGG ID D00690
MeSH ID D000068656
PubChem ID 441336
TTD Drug ID D03HYX
NDC Product Code 63187-288; 78206-111; 63629-8681; 63190-0730; 10599-003; 63629-8686; 62991-3098; 16714-974; 68462-225; 0168-0270; 63629-8682; 60429-664; 63187-432; 11517-434; 71161-133; 64918-0330; 50090-1026; 71205-413; 51552-1510; 0713-0634; 0168-0272; 68462-385; 78206-115; 10695-111; 50909-5151; 78206-114; 0713-0635; 64918-0424; 13668-527; 78206-112; 70518-3244; 46439-8733; 63592-0387; 68462-192; 58175-1234; 52128-163; 0168-0271; 0713-0701; 63190-0340; 63592-0397; 45802-118; 60505-0830; 53002-8320; 70518-2883; 78206-113; 68071-4637; 63629-8683; 15308-0220; 51672-1311; 75895-0280; 63629-8685; 75895-0279; 11517-222; 0713-0726; 68071-4460; 68071-1538; 65089-0025; 11517-433; 22552-0002; 45802-119; 53104-7646; 51927-4506; 53002-8321; 45802-257; 0713-0727; 63629-8684; 38779-2413; 51672-1305; 51672-1315
Synonyms Mometasone Furoate | Furoate, Mometasone | Nasonex | Mometasone Furoate Monohydrate | Furoate Monohydrate, Mometasone | Monohydrate, Mometasone Furoate | Asmanex Twisthaler | Twisthaler, Asmanex | Asmanex | Rinelon | Elocon | Sch 32088 | Sch-32088 | Sch32088 | Mometasone
Chemical Information
Molecular Formula C27H30Cl2O6
CAS Registry Number 83919-23-7
SMILES CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)OC(=O)C5=CC=CO5)C)O)Cl)C
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Influenza like illness08.01.03.0100.000994%
Injury12.01.08.004--Not Available
Insomnia17.15.03.002; 19.02.01.0020.003481%
Intraocular pressure increased13.07.04.0020.001740%Not Available
Irritability19.04.02.013; 08.01.03.011--
Joint swelling15.01.02.0040.000746%Not Available
Laceration23.03.11.004; 12.01.06.006--Not Available
Lacrimation increased06.08.02.0040.000746%
Laryngitis22.07.03.001; 11.01.13.0010.000994%
Leukoderma23.05.02.001--Not Available
Lip swelling23.04.01.007; 10.01.05.005; 07.05.04.0050.000497%Not Available
Loss of consciousness17.02.04.004--Not Available
Lung disorder22.02.07.0010.001492%Not Available
Lymphadenopathy01.09.01.0020.000746%Not Available
Malaise08.01.01.0030.004724%
Mass08.03.05.0030.000497%Not Available
Memory impairment19.20.01.003; 17.03.02.003--
Meningioma17.20.01.005; 16.30.01.0050.000497%Not Available
Menstrual disorder21.01.01.004--Not Available
Miliaria23.02.03.014--Not Available
Mood swings19.04.03.0010.000497%Not Available
Musculoskeletal pain15.03.04.007--
Myalgia15.05.02.0010.001989%
Nasal congestion22.04.04.0010.012928%
Nasal dryness22.04.03.0020.001243%Not Available
Nasal inflammation22.04.04.0020.000497%Not Available
Nasal polyps22.04.03.010; 16.38.01.0010.000497%Not Available
Nasal septum perforation22.04.03.003--Not Available
Nasal ulcer22.04.03.0110.000746%Not Available
Nasopharyngitis22.07.03.002; 11.01.13.0020.003978%Not Available
The 4th Page    First    Pre   4 5 6 7 8    Next   Last    Total 8 Pages